Vyant Bio Net Tangible Assets

Vyant Bio (VYNT) currently reports a net tangible assets of $9.9M as of December 2022. That compares with $31M in the prior-year period — down 68.3% year over year. Use the charts on this page to explore Vyant Bio's net tangible assets history and peer comparisons.

Vyant Bio's net tangible assets decreased from $31M to $9.9M — a 68.3% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vyant Bio reported $9.9M in net tangible assets as of December 2022. That compares with $31M in the prior-year period — down 68.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $9.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vyant Bio, and consider following VYNT for alerts when major investors trade the stock.

Vyant Bio is classified in the Healthcare sector. On net tangible assets, it currently shows $9.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VYNT with unrelated industries.